Precision of Biomarkers to Define Chronic Inflammation in CKD | Zendy

Robert E. LaClair | Zendy; Kalisha O’Neal | Zendy; Susan Ofner | Zendy; M.J. Sosa | Zendy; Carlos A. Labarrere | Zendy; Sharon M. Moe | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Precision of Biomarkers to Define Chronic Inflammation in CKD

Author(s) -

Robert E. LaClair,

Kalisha O’Neal,

Susan Ofner,

M.J. Sosa,

Carlos A. Labarrere,

Sharon M. Moe

Publication year - 2008

Publication title -

american journal of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.394

H-Index - 85

eISSN - 1421-9670

pISSN - 0250-8095

DOI - 10.1159/000135692

Subject(s) - medicine , dialysis , surrogate endpoint , subclinical infection , intraclass correlation , kidney disease , biomarker , clinical trial , population , intensive care medicine , clinical psychology , biochemistry , chemistry , environmental health , psychometrics

Several inflammatory biomarkers have been found to be associated with cardiovascular disease or all-cause mortality in dialysis patients, but their usefulness in clinical practice or as surrogate endpoints is not certain. The purpose of the present study was to determine the intrapatient variation of C-reactive protein, IL-6, fetuin-A and albumin in a population of dialysis patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research